AzTrials
AzTrials

Adenoidectomy SurgeryPhase 4NCT02708043

Laryngeal Mask Airway for Adenoidectomies (LMAA)

A Phase 4 study testing Flexible-Laryngeal Mask Airway in people with Adenoidectomy Surgery and Flexible-Laryngeal Mask Airway, run by Baskent University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study retrospectively assesses laryngeal mask airway use during pediatric adenoidectomies in terms of patient safety, comfort, complications and surgeon satisfaction levels. Read more about this study

Who is it for?
Ages 1 year to 16 years
What is being tested?
Flexible-Laryngeal Mask Airway
Could I receive a placebo?
No, everyone receives an active treatment
How many people
814 participants
Where
No sites listed yet
Study dates
Jun 2012to Dec 2015
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 1-16 years of age
  • ASA I-II
  • Scheduled for elective adenoidectomy under general anesthesia with F-LMA between June 2012 and November 2015.

Who cannot join

  • Emergency
  • Extreme obesity
  • Sign of clinical significant infection.

About this study

Official title: The Use of Laryngeal Mask Airway for Adenoidectomies: An Experience of 814 Paediatric Patients

The current study retrospectively assesses laryngeal mask airway use during pediatric adenoidectomies in terms of patient safety, comfort, complications and surgeon satisfaction levels.

Being tested
Flexible-Laryngeal Mask Airway

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Flexible-Laryngeal Mask AirwayOther

Study groups in NCT02708043
Study groupRoleWhat they receive
F-LMA groupOtherLMA were placed to 814 patients for adenoidectomy surgery. Researchers evaluated flexible laryngeal mask airway use during pediatric adenoidectomies in terms of patient safety, comfort, complications and surgeon satisfaction levels.
Receives: Other: Flexible-Laryngeal Mask Airway

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of failed LMA (0=failed, 1=good)

    Measured: 3 year

Secondary outcomes (1)
  1. Surgeon satisfaction level (0=bad, 1=same, 2=good)

    Measured: 3 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2016 (estimated)
  2. Study startJun 2012
  3. Primary completionNov 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
814 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02708043
Sponsor's protocol ID
KA 15-321
Status last verified
Mar 2016
First submitted
21 Feb 2016
Last updated
15 Mar 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Flexible-Laryngeal Mask Airway in people with Adenoidectomy Surgery and Flexible-Laryngeal Mask Airway, run by Baskent University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of failed LMA (0=failed, 1=good) (time frame: 3 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in